3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Prostatic Neoplasms
7
Colorectal Neoplasms
4
Breast Neoplasms
4
Small Cell Lung Carcinoma
3
Neoplasms
3
Lung Neoplasms
3
Stomatitis
2
Male Urogenital Diseases
2
Cardiovascular Diseases
2
Carcinoma, Non-Small-Cell Lung
2
Vascular Diseases
1
Ulcer
1
Sexual Dysfunction, Physiological
1
Rectal Neoplasms
1
Radiation-induced Injuries in Patients With Rectal Cancer
1
Radiation Injuries
1
Polycystic Ovary Syndrome
1
Ovarian Neoplasms
1
Non-melanoma Skin Cancer
1
Neurotoxicity Syndromes
1
Myocardial Ischemia
1
Myocardial Infarction
1
Lymphoma, Follicular
1
Heart Diseases
1
Head and Neck Neoplasms
1
Fibrosis
1
Fatigue
1
Eye Diseases
1
Erectile Dysfunction
1
Dyspareunia
1
Interventions
beta Carotene
1
Vitamin E
1
Surgical Procedures, Operative
1
Immune Checkpoint Inhibitors
1
Geritol
1
Biopsy
1
Ascorbic Acid
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Eye Diseases
×
Vitamin E
×
Clear all
NCT00270647
2018-02-28
PHS II
Brigham and Women's Hospital
Phase NA
Completed
14,641 enrolled